Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4
Authors
Keywords
-
Journal
Diabetes Technology & Therapeutics
Volume -, Issue -, Pages -
Publisher
Mary Ann Liebert Inc
Online
2022-05-12
DOI
10.1089/dia.2022.0084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- Randomized Crossover Comparison of Automated Insulin Delivery vs. Conventional Therapy using an Unlocked Smartphone with Scheduled Pasta and Rice Meal Challenges in the Outpatient Setting
- (2020) Sunil Deshpande et al. Diabetes Technology & Therapeutics
- Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
- (2020) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
- (2020) Marc D. Breton et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp
- (2019) Emilie Palisaitis et al. Diabetes Technology & Therapeutics
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance
- (2018) Ravi Gondhalekar et al. AUTOMATICA
- Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise
- (2018) Jordan E. Pinsker et al. Diabetes Technology & Therapeutics
- First Look at Control-IQ: A New-Generation Automated Insulin Delivery System
- (2018) Sue Brown et al. DIABETES CARE
- Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development
- (2018) Sunil Deshpande et al. Diabetes Technology & Therapeutics
- Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
- (2017) Lia Bally et al. Lancet Diabetes & Endocrinology
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Home Use of an Artificial Beta Cell in Type 1 Diabetes
- (2015) Hood Thabit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
- (2015) Ahmad Haidar et al. Lancet Diabetes & Endocrinology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now